Purpose: To determine the effect of intraoperative ophthalmic viscosurgical devices (OVDs) on late opacification of the Hydroview hydrogel intraocular lens (IOL) (Bausch & Lomb Surgical).
Setting: Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.
Methods: A retrospective study of 949 cases of Hydroview IOL implantations from February 1998 to September 2000 was conducted.
Purpose: To report clinical and laboratory findings of 8 cases of toxic anterior segment syndrome (TASS) related to an oily substance in the anterior chamber of patients following cataract surgery with intraocular lens (IOL) implantation.
Setting: John Moran Eye Center, University of Utah, Salt Lake City, Utah, USA.
Methods: Eight patients had uneventful phacoemulsification by the same surgeon via clear corneal incisions with implantation of the same 3-piece silicone IOL design.